Regeneron Pharmaceuticals Inc (REGN)

Total asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	14,202,000	13,044,200	12,113,500	16,014,400	8,440,200
Total assets	US$ in thousands	37,759,400	33,080,200	29,214,500	25,434,800	17,163,300
Total asset turnover		0.38	0.39	0.41	0.63	0.49

December 31, 2024 calculation

Total asset turnover = Revenue ÷ Total assets
= $14,202,000K ÷ $37,759,400K
= 0.38

Regeneron Pharmaceuticals Inc's total asset turnover ratio has fluctuated over the past five years. In December 2020, the total asset turnover stood at 0.49, indicating that the company generated $0.49 in revenue for every dollar of assets during that period.

By December 2021, the total asset turnover ratio improved to 0.63, suggesting the company became more efficient in utilizing its assets to generate revenue. However, this trend reversed in the subsequent years, with ratios dropping to 0.41 in 2022, 0.39 in 2023, and further to 0.38 in 2024.

The declining trend in total asset turnover may indicate challenges in effectively utilizing the company's assets to generate revenue or that the company's sales growth may not be keeping pace with asset growth. It could also signal potential inefficiencies in operations or underperformance compared to industry peers. Further investigation into the company's operational efficiency and asset management practices may be warranted to address these concerns.